Magazine Article | January 3, 2023

Phase 1 Study Complexity

Source: Life Science Leader

By Industry Standard Research

ISR recently ran a survey to assess dynamics in the Phase 1 clinical development space. Over 80% of respondents believe Phase 1 studies are getting more complex. Respondents also shared the percentages of their companys’ Phase 1 studies that use various practices. Over half of Phase 1 studies are executed in multiple sites/centers while about one-third take place in multiple countries. Additional locations and geographies create more complexity for study managers to juggle. Forty percent of studies take place in hospitals or academic centers, which can lead to more bureaucracy to navigate.

VIEW THE MAGAZINE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader